Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED)

v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Deficit
Series A-1 Preferred
Series A-1 Preferred
Preferred Stock
Series S-1 Preferred
Preferred Stock
Series B Preferred
Preferred Stock
Series M Preferred
Preferred Stock
Beginning balance (in shares) at Dec. 31, 2022             222,588 100,000    
Beginning balance at Dec. 31, 2022 $ 2,307 $ 2 $ 45,748 $ (42,822) $ (621)   $ 0 $ 0    
Beginning balance (in shares) at Dec. 31, 2022   3,150,230                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share based compensation 8   8              
Common stock issued for equity financing (in shares)   361,000                
Common stock issued for equity financing 369 $ 1 368              
Series A-1 Preferred converted for legal settlement (in shares)   103,707         (5,185)      
Series A-1 Preferred converted for legal settlement 170   170              
Other comprehensive income 621       621          
Net income 10,085     10,085            
Ending balance (in shares) at Apr. 01, 2023             217,403 100,000    
Ending balance at Apr. 01, 2023 13,560 $ 3 46,294 (32,737) 0   $ 0 $ 0    
Ending balance (in shares) at Apr. 01, 2023   3,614,937                
Beginning balance (in shares) at Dec. 31, 2022             222,588 100,000    
Beginning balance at Dec. 31, 2022 2,307 $ 2 45,748 (42,822) (621)   $ 0 $ 0    
Beginning balance (in shares) at Dec. 31, 2022   3,150,230                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 9,993                  
Ending balance (in shares) at Sep. 30, 2023             193,730 100,000    
Ending balance at Sep. 30, 2023 14,498 $ 3 47,323 (32,828) 0   $ 0 $ 0    
Ending balance (in shares) at Sep. 30, 2023   4,957,647                
Beginning balance (in shares) at Apr. 01, 2023             217,403 100,000    
Beginning balance at Apr. 01, 2023 13,560 $ 3 46,294 (32,737) 0   $ 0 $ 0    
Beginning balance (in shares) at Apr. 01, 2023   3,614,937                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share based compensation 5   5              
Net income 123     123            
Ending balance (in shares) at Jul. 01, 2023             217,403 100,000    
Ending balance at Jul. 01, 2023 13,688 $ 3 46,299 (32,614) 0   $ 0 $ 0    
Ending balance (in shares) at Jul. 01, 2023   3,614,937                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share based compensation 1   1              
Common stock issued for equity financing (in shares)   418,000                
Common stock issued for equity financing 424   424              
Series A-1 Preferred converted for legal settlement (in shares)   443,362         (22,168)      
Series A-1 Preferred converted for legal settlement $ 340   340              
Series A-1 Preferred Stock forfeited (in shares)             (1,505)      
Common stock issued for consulting agreement (in shares) 0                  
Warrants exercised (in shares)   481,348                
Warrants exercised $ 259   259              
Net income (214)     (214)            
Ending balance (in shares) at Sep. 30, 2023             193,730 100,000    
Ending balance at Sep. 30, 2023 14,498 $ 3 47,323 (32,828) 0   $ 0 $ 0    
Ending balance (in shares) at Sep. 30, 2023   4,957,647                
Beginning balance (in shares) at Dec. 30, 2023           193,730 193,730 100,000 0 0
Beginning balance at Dec. 30, 2023 $ (3,308) $ 3 47,323 (50,634) 0   $ 0 $ 0 $ 0 $ 0
Beginning balance (in shares) at Dec. 30, 2023 4,957,647 4,957,647                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share based compensation $ 345   345              
Reclassification of Series S stock to liability (339)   (339)              
Reclassification of Series S stock to permanent equity 7,993                  
Common stock issued for equity financing (in shares)   884,880                
Common stock issued for equity financing 627 $ 1 626              
Common stock issued for consulting agreement (in shares)   200,000                
Common stock issued for consulting agreement 232   232              
Common stock issued in lieu of notes payable obligation (in shares)   600,000                
Common stock issued in lieu of notes payable obligation 367 $ 1 366              
Common stock issued for RSU's granted (in shares)   908,852                
Net income (2,144)     (2,144)            
Ending balance (in shares) at Mar. 30, 2024             193,730 100,000 0 0
Ending balance at Mar. 30, 2024 3,773 $ 5 48,553 (52,778) 0   $ 0 $ 0 $ 0 $ 0
Ending balance (in shares) at Mar. 30, 2024   7,551,379                
Beginning balance (in shares) at Dec. 30, 2023           193,730 193,730 100,000 0 0
Beginning balance at Dec. 30, 2023 $ (3,308) $ 3 47,323 (50,634) 0   $ 0 $ 0 $ 0 $ 0
Beginning balance (in shares) at Dec. 30, 2023 4,957,647 4,957,647                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Reclassification of Series S stock to permanent equity $ 8,000                  
Series A-1 Preferred converted for legal settlement (in shares)           170,250        
Net income (2,377)                  
Ending balance (in shares) at Sep. 28, 2024           23,480 23,480 100,000 34,207 3,200
Ending balance at Sep. 28, 2024 $ 20,225 $ 7 59,679 (53,011) (2,995)   $ 0 $ 0 $ 8,552 $ 0
Ending balance (in shares) at Sep. 28, 2024 14,019,015 14,019,015                
Beginning balance (in shares) at Mar. 30, 2024             193,730 100,000 0 0
Beginning balance at Mar. 30, 2024 $ 3,773 $ 5 48,553 (52,778) 0   $ 0 $ 0 $ 0 $ 0
Beginning balance (in shares) at Mar. 30, 2024   7,551,379                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share based compensation (in shares)   295,000                
Share based compensation 1,161   1,161              
Stock issued for acquisition of Alt5 Subsidiary (in shares)   1,799,115             34,207 3,200
Stock issued for acquisition of Alt5 Subsidiary 7,448 $ 1 7,447           $ 8,552  
Conversion of note receivable to common stock (in shares)   200,000                
Conversion of note receivable to common stock 122   122              
Common stock issued for equity financing (in shares)   120,598                
Common stock issued for equity financing 342   342              
Series A-1 Preferred converted for legal settlement (in shares)   2,125,000         (123,750)      
Common stock issued for consulting agreement (in shares)   197,923                
Common stock issued for consulting agreement 580 $ 1 579              
Common stock issued for property and equipment (in shares)   300,000                
Common stock issued for property and equipment 1,170   1,170              
Foreign currency adjustment (807)       (807)          
Net income 589     589            
Ending balance (in shares) at Jun. 29, 2024             69,980 100,000 34,207 3,200
Ending balance at Jun. 29, 2024 22,930 $ 7 59,374 (52,189) (807)   $ 0 $ 0 $ 8,552 $ 0
Ending balance (in shares) at Jun. 29, 2024   12,589,015                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Conversion of notes payable to common stock (in shares)   500,000                
Conversion of notes payable to common stock $ 305   305              
Series A-1 Preferred converted for legal settlement (in shares)   930,000         (46,500)      
Common stock issued for consulting agreement (in shares) 0                  
Foreign currency adjustment $ (2,188)       (2,188)          
Net income (822)     (822)            
Ending balance (in shares) at Sep. 28, 2024           23,480 23,480 100,000 34,207 3,200
Ending balance at Sep. 28, 2024 $ 20,225 $ 7 $ 59,679 $ (53,011) $ (2,995)   $ 0 $ 0 $ 8,552 $ 0
Ending balance (in shares) at Sep. 28, 2024 14,019,015 14,019,015